Stock Price Forecast

April 22, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading STAAR SURGICAL CO chart...

About the Company

We do not have any company description for STAAR SURGICAL CO at the moment.

Exchange

Nasdaq

$322M

Total Revenue

644

Employees

$2B

Market Capitalization

113.06

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $STAA News

Staar’s Surge: US Sales Surprises Investors

2d ago, source: Orange County Business Journal

Staar may make its Evo Viva lenses at its Lake Forest HQ Staar Surgical Co. surprised Wall Street earlier this month by ...

Staar Surgical Holds Promise Amid Strong Q1 Performance, Yet Cautious Outlook Justifies Hold Rating

18d ago, source: Business Insider

Begin your TipRanks Premium journey today. Staar Surgical (STAA) Company Description: STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable ...

In-Depth Examination Of 4 Analyst Recommendations For Staar Surgical

19d ago, source: Business Insider

Unveiling the Story Behind Staar Surgical Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to ...

Midday Stock Roundup: BioCorRx Drops Over 50%

2d ago, source: Orange County Business Journal

The yield on a 10-year bond rose 3% to 4.497%. STAAR Surgical Co. (Nasdaq: STAA), the Lake Forest-based maker of implantable eye lenses, rose 6% to $52.45 per share for a market cap of $2.6 billion.

Staar Surgical Co. (STAA) Forecast: Revisiting The Past To Gain Insights For The Future

11d ago, source:

Staar Surgical Co. (NASDAQ:STAA) concluded the trading at $49.79 on Friday, April 12 with a fall of -3.51% from its closing price on previous day.

STAAR Surgical Celebrates Three Million Lens Milestone at ASCRS Meeting, Unveils New EVO ICL Data and Latest Innovation for 2024

21d ago, source: Stockhouse

STAAR Surgical Company (NASDAQ: STAA), a leading developer ... will be presented by Taj Nasser, MD, and co-authors. This is the largest US commercial use outcomes paper to-date following FDA approval ...

Staar Surgical Co STAA

14d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In-Depth Examination Of 4 Analyst Recommendations For Staar Surgical

19d ago, source: Benzinga.com

Stay informed and make strategic decisions with our Ratings Table. Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and ...

Staar Surgical Co.

9d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...